Theravance Biopharma TBPH Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's accrued manufacturing costs?
- Theravance Biopharma (TBPH) reported accrued manufacturing costs of $8.73M in Q1 2026.
- How has Theravance Biopharma's accrued manufacturing costs changed year-over-year?
- Theravance Biopharma's accrued manufacturing costs increased by 62.1% year-over-year, from $5.39M to $8.73M.
- What is the long-term trend for Theravance Biopharma's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Theravance Biopharma's accrued manufacturing costs has grown at a -18.6% compound annual growth rate (CAGR), from $35.24M to $12.59M.